Wegener's granulomatosis

Autoimmunity

Volumn 37, Issue 4, 2004, Pages 313-315

  Slot, Marjan C ^a   Tervaert, Jan Willem Cohen ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; AZATHIOPRINE; CYCLOPHOSPHAMIDE; MYELOBLASTIN; MYELOPEROXIDASE; NEUTROPHIL CYTOPLASMIC ANTIBODY; PREDNISOLONE;

ANTIBODY SPECIFICITY; ANTIBODY TITER; ARTICLE; DIAGNOSTIC VALUE; DISEASE MARKER; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOFLUORESCENCE TEST; PREDICTION; RECURRENCE RISK; RELAPSE; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; SURVIVAL RATE; WEGENER GRANULOMATOSIS;

ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; BIOLOGICAL MARKERS; HUMANS; PROGNOSIS; TIME FACTORS; WEGENER GRANULOMATOSIS;

EID: 4444273042     PISSN: 08916934     EISSN: None     Source Type: Journal    
DOI: 10.1080/08916930410001708724     Document Type: Article

References (41)

1. Godman, G.C. and Churg, J. (1954) "Wegener's granulomatosis: pathology and review of the literature", Arch. Pathol. 58, 533-553.
2. Walton, E.W. (1958) "Giant-cell granuloma of the respiratory tract (Wegener's granulomatosis)", Br. Med. J. 2, 265-270.
3. Aasarød, K., Iversen, B.M., Hammerstrøm, J., Bostad, L., Vatten, L. and Jørstad, S. (2000) "Wegener's granulomatosis: clinical course in 108 patients with renal involvement", Nephrol. Dial. Transplant. 15, 611-618.
4. Hoffman, G.S., Kerr, G.S., Leavitt, R.Y., Hallahan, C.W., Lebovics, R.S., Travis, W.D., et al. (1992) "Wegener's granulomatosis: an analysis of 158 patients", Ann. Intern. Med. 116, 488-498.
5. Reinhold-Keller, E., Beuge, N., Latza, U., de Groot, K., Rudert, H., Nolle, B., et al. (2000) "An interdisciplinary approach to the care of patients with Wegener's granulomatosis", Arthritis Rheum. 43, 1021-1032
6. Westman, K.W.A., Selga, D., Isberg, P.-E., Bladstrom, A. and Olsson, H. (2003) "High proteinase 3-anti-neutrophil cytoplasmic antibody (ANCA) level measured by the capture enzyme-linked immunosorbent assay method is associated with decreased patient survival in ANCA-associated vasculitis with renal involvement", J. Am. Soc. Nephrol. 14, 2926-2933.
7. Jennette, J.C. and Falk, R.J. (1997) "Small-vessel vasculitis", N. Engl. J. Med. 337, 1512-1523.
8. Velosa, J.A., Homburger, H.A. and Holley, K.E. (1993) "Prospective study of anti-neutrophil cytoplasmic autoantibody tests in the diagnosis of idiopathic necrotizing-crescentic glomerulonephritis and renal vasculitis", Mayo Clin. Proc. 68, 561-565.
9. Cohen Tervaert, J.W., Goldschmeding, R., Elema, J.D., van der Giessen, M., Huitema, M.G., Van der Hem, G.K., et al. (1990) "Autoantibodies against myeloid lysosomal enzymes in crescentic glomerulonephritis", Kidney Int. 37, 799-806.
10. Boomsma, M.M., Stegeman, C.A., van der Leij, M.J., Oost-Kort, W.W., Hermans, J., Kallenberg, C.G.M., et al. (2000) "Prediction of relapses in Wegener's granulomatosis by measurement of antineutrophil cytoplasmic antibody levels: a prospective study", Arthritis Rheum. 43, 2025-2033.
11. Cohen Tervaert, J.W., van der Woude, F.J., Fauci, A.S., Ambrus, J.L., Velosa, J., Keane, W.F., et al. (1989) "Association between active Wegener's granulomatosis and anticytoplasmic antibodies", Arch. Intern. Med. 149, 2461-2465.
12. Falk, R.J., Terrell, R.S., Charles, L.A. and Jeanette, J.C. (1990) "Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro", Proc. Natl Acad. Sci. USA 87, 4115-4119.
13. Muller Kobold, A.C., Limburg, PC., Cohen Tervaert, J.W. and Kallenberg, C.G.M. (1999) "Pathophysiology of ANCA-associated glomerulonephritis", Nephrol. Dial. Transplant. 14, 1366-1375.
14. Heeringa, P., Brouwer, E., Cohen Tervaert, J.W., Weening, J.J. and Kallenberg, C.G.M. (1998) "Animal models of anti-neutrophil cytoplasmic antibody associated vasculitis", Kidney Int. 53, 253-263.
15. Xiao, H., Heeringa, P., Hu, P., Liu, Z., Zhao, M., Aratani, Y., et al. (2002) "Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase (MPO-ANCA) cause glomerulonephritis and vasculitis in mice", J. Clin. Investig. 110, 955-963.
16. Csernok, E. (2003) "Anti-neutrophil cytoplasmic antibodies and pathogenesis of small vessel vasculitides", Autoimmun. Rev. 2, 158-164.
17. Merkel, P. (1998) "Drugs associated with vasculitis", Curr. Opin. Rheumatol. 10, 45-50.
18. Pendergraft, W.F., Preston, G.A., Shah, R.R., Tropsha, A., Carter, C.W., Jennette, J.C., et al. (2004) "Autoimmunity is triggered by cPR-3(105-201), a protein complementary to human autoantigen proteinase-3", Nat. Med. 10, 72-79.
19. Davies, D.J., Moran, J.E., Niall, J.F. and Ryan, G.B. (1982) "Segmental necrotising glomerulonephritis with antineutrophil antibody: possible arbovirus aetiology?", Br. Med. J. 2, 606.
20. van der Woude, F.J., Rasmussen, N., Lobatto, S., Wiik, A., Permin, H., van Es, L.A., et al. (1985) "Autoantibodies against neutrophils and monocytes: tool for diagnosis and marker of disease activity in Wegener's granulomatosis", Lancet i, 425-429.
21. Choi, H.K., Liu, S., Merkel, P.A., Colditz, G.A. and Niles, J.L. (2001) "Diagnostic performance of antineutrophil cytoplasmic antibody tests for idiopathic vasculitides: metaanalysis with a focus on antimyeloperoxidase antibodies", J. Rheumatol. 28, 1584-1590.
22. Rao, J.K., Weinberger, M., Oddone, E.Z., Allen, N.B., Landsman, P. and Feussner, J.R. (1995) "The role of antineutrophil cytoplasmic antibody (c-ANCA) testing in the diagnosis of Wegener granulomatosis. A literature review and meta-analysis", Ann. Intern. Med. 123, 925-932.
23. Vassilopoulos, D. and Hoffman, G.S. (1999) "Clinical utility of testing for antineutrophil cytoplasmic antibodies", Clin. Diagn. Lab. Immunol. 6, 645-651.
24. Merkel, P.A., Polisson, R.P., Chang, Y., Skates, S.J. and Niles, J.L. (1997) "Prevalence of antineutrophil cytoplasmic antibodies in a large inception cohort of patients with connective tissue disease", Ann. Intern. Med. 126, 866-873.
25. Jayne, D., Rasmussen, N., Andrassy, K., Bacon, P., Cohen Tervaert, J.W., Dadoniene, J., et al. (2003) "A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies", N. Engl. J. Med. 349, 36-44.
26. Stegeman, C.A. (2002) "Anti-neutrophil cytoplasmic antibody (ANCA) levels directed against proteinase-3 and myeloperoxidase are helpful in predicting disease relapse in ANCA-associated small-vessel vasculitis", Nephrol. Dial. Transplant. 17, 2077-2080.
27. Slot, M.C., Boomsma, M.M., Cohen Tervaert, J.W. and Stegeman, C.A. (2004) "A positive C-ANCA titer at switch to azathioprine therapy is associated with a disquieting relapse rate in PR3-ANCA-related vasculitis", Arthritis Rheum. 51, 269-273.
28. Kyndt, X., Reumaux, D., Bridoux, F., Tribout, B., Bataille, P., Hachulla, E., et al. (1999) "Serial measurements of antineutrophil cytoplasmic autoantibodies in patients with systemic vasculitis", Am. J. Med. 106, 527-533.
29. De'Oliviera, J., Gaskin, G., Dash, A., Rees, A.J. and Pusey, C.D. (1995) "Relationship between disease activity and anti-neutrophil cytoplasmic antibody concentration in long-term management of systemic vasculitis", Am. J. Kidney Dis. 25, 380-389.
30. Hogan, S.L., Nachman, P.H., Wilkman, A.S., Jennette, J.C. and Falk, R.J. (1996) "Prognostic markers in patients with antineutrophil cytoplasmic autoantibody-associated microscopic polyangiitis and glomerulonephritis", J. Am. Soc. Nephrol. 7, 23-32.
31. Geffriaud-Ricouard, C., Noel, L.H., Chauveau, D., Houhou, S., Grunfeld, J.P. and Lesavre, P. (1993) "Clinical spectrum associated with ANCA of defined antigen specificities in 98 selected patients" , Clin. Nephrol. 39, 125-136.
32. Franssen, C.F.M., Gans, R.O., Arends, B., Hageluken, C., ter Wee, P.M., Gerlag, P.G., et al. (1995) "Differences between anti-myeloperoxidase- and anti-proteinase 3-associated renal disease", Kidney Int. 47, 193-199.
33. Vizjak, A., Rott, T., Koselj-Kajtna, M., Rozman, B., Kaplan-Pavlovcic, S. and Ferluga, D. (2003) "Histologic and immunohistologic study and clinical presentation of ANCA-associated glomerulonephritis with correlation to ANCA antigen specificity", Am. J. Kidney Dis. 41, 539-549.
34. Falk, R.J., Hogan, S., Carey, T.S. and Jennette, J.C. (1990) "Clinical course of anti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis and systemic vasculitis. The Glomerular Disease Collaborative Network", Ann. Intern. Med. 113, 656-663.
35. Slot, M.C., Cohen Tervaert, J.W., Franssen, C.F.M. and Stegeman, C.A. (2003) "Renal survival and prognostic factors in patients with PR3-ANCA associated vasculitis with renal involvement" , Kidney Int. 63, 670-677.
36. Franssen, C.F.M., Stegeman, C.A., Oost-Kort, W.W., Kallenberg, C.G.M., Limburg, P.C., Tiebosch, A.T.M.G., et al. (1998) "Determinants of renal outcome in anti-myeloperoxidase-associated necrotizing crescentic glomerulonephritis", J. Am. Soc. Nephrol. 9, 1915-1923.
37. Girard, T., Mahr, A., Noel, L.H., Cordier, J.F., Lesavre, P., Andre, M.H., et al. (2001) "Are antineutrophil cytoplasmic antibodies a marker predictive of relapse in Wegener's granulomatosis? A prospective study", Rheumatology (Oxf.) 40, 147-151.
38. Stegeman, C.A., Cohen Tervaert, L.W., Sluiter, W.J., Manson, W.L., de Jong, P.E. and Kallenberg, C.G.M. (1994) "Association of chronic nasal carriage of Staphylococcus aureus and higher relapse rates in Wegener granulomatosis", Ann. Intern. Med. 120, 12-17.
39. Kerr, G.S., Fleisher, T.A., Hallahan, C.W., Leavitt, R.Y., Fauci, A.S. and Hoffman, G.S. (1993) "Limited prognostic value of changes in antineutrophil cytoplasmic antibody titer in patients with Wegener's granulomatosis", Arthritis Rheum. 36, 365-371.
40. Han, W.K., Choi, H.K., Roth, R.M., McCluskey, R.T. and Niles, J.L. (2003) "Serial ANCA titers: useful tool for prevention of relapses in ANCA-associated vasculitis", Kidney Int. 63, 1079-1085.
41. Cohen Tervaert, J.W., Huitema, M.G., Hene, R.J., Sluiter, W.J., The, T.H., Van der Hem, G.K., et al. (1990) "Prevention of relapses in Wegener's granulomatosis by treatment based on antineutrophil cytoplasmic antibody titre", Lancet 336, 709-711.